SEC Comment Letter 0000000000-24-005640 to Rallybio Corp (RLYB) (CIK 0001739410) (RLYB)
Rallybio Corp (RLYB) (CIK 0001739410)
Date: May 16, 2024 · CIK: 0001739410 · Accession: 0000000000-24-005640
AI Filing Summary & Sentiment
File numbers found in text: 333-279317
Letter
United States securities and exchange commission logo May 16, 2024 Stephen Uden, M.D. Chief Executive Officer Rallybio Corporation 234 Church Street, Suite 1020 New Haven, CT 06510 Re:Rallybio Corporation Registration Statement on Form S-3 Filed May 10, 2024 File No. 333-279317 Dear Stephen Uden: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Zachary Blume, Esq.
Show Raw Text
United States securities and exchange commission logo
May 16, 2024
Stephen Uden, M.D.
Chief Executive Officer
Rallybio Corporation
234 Church Street, Suite 1020
New Haven, CT 06510
Re:Rallybio Corporation
Registration Statement on Form S-3
Filed May 10, 2024
File No. 333-279317
Dear Stephen Uden:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Zachary Blume, Esq.